NCT03268213View on ClinicalTrials.gov

Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

February 15, 2022

Study Completion Date

February 15, 2022

Conditions
Clostridium Difficile InfectionUlcerative ColitisIndeterminate Colitis
Interventions
BIOLOGICAL

Fecal Microbial Transplantation

"Fecal microbial transplant is offered as treatment option to eligible patients. Donors selected by the patients will be screened by questionnaire and by blood and stool tests for potential transmissible pathogens.~The stool filtrate will be administered in the ileum and/or cecum via colonoscopy"

Trial Locations (1)

11794

Stony Brook University Hospital, Stony Brook

All Listed Sponsors
lead

Stony Brook University

OTHER

NCT03268213 - Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis | Biotech Hunter | Biotech Hunter